Novacyt

Novacyt Inventory/Revenue

The Inventory to Revenue Ratio of Novacyt (ALNOV.PA) as of Nov 3, 2026 is 12.42 %. In the previous year, Inventory to Revenue Ratio was 11.56 % — a change of 7.47% (higher).

Inventory/Revenue

12.42 %

YoY

7.47%

Last updated:

Inventory to Revenue Ratio of Novacyt is 2025 12.42 % . Inventory to Revenue Ratio of Novacyt was 2024 11.56 % . It decreases by 7.47% higher compared to the previous year.

The Novacyt Inventory/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory/Revenue
Date
Inventory/Revenue
Jan 1, 2018
15.42 GBP
Jan 1, 2019
15.94 GBP
Jan 1, 2020
10.78 GBP
Jan 1, 2021
12.38 GBP
Jan 1, 2022
14.39 GBP
Jan 1, 2023
26.10 GBP
Jan 1, 2024
11.56 GBP
Jan 1, 2025
12.42 GBP
The Novacyt Inventory/Revenue history
YEARInventory/RevenueYoY
12.42 %+7.47%
11.56 %-55.71%
26.10 %+81.41%
14.39 %+16.24%
12.38 %+14.79%
10.78 %-32.36%
15.94 %+3.38%
15.42 %+1.23%
15.23 %+22.54%
12.43 %+0.54%
12.36 %-46.42%
23.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novacyt Stock analysis

What does Novacyt do? Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. The company was founded in 2006 and has experienced impressive growth since then. Its headquarters are located in Paris. Novacyt's business model revolves around the development and marketing of diagnostic products and technologies, particularly molecular diagnostic kits and reagents used for identification and quantification of microorganisms, viruses, and genetic differences. These products are commonly used in medical research, clinical diagnostics, and environmental analysis. Novacyt is divided into several divisions, each offering different products and services. Its diagnostic business specializes in the research, development, and marketing of molecular diagnostic kits, including the Primerdesign Kits specifically designed for COVID-19 identification. The company also provides laboratory and service offerings, such as DNA sequencing, qPCR analysis, sample preparation, and PCR disinfection. Additionally, Novacyt offers various diagnostic tests capable of detecting genetic differences and mutations. Its PathFlow division focuses on improving the process from diagnosis to therapy and follow-up, particularly for oncology patients. In response to the COVID-19 pandemic, Novacyt quickly launched a PCR test kit for COVID-19, which has been approved in numerous countries worldwide. Novacyt has successfully established itself as a key player in the fight against the pandemic. In summary, Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. Through its divisions, the company ensures the optimal utilization of molecular diagnostic tests. Novacyt has become an important player in the fight against the pandemic through its rapid response and development of molecular diagnostic kits for COVID-19, establishing itself as a reliable and innovative partner for medical research and clinical diagnostics. Novacyt is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novacyt stock

Inventory to Revenue Ratio of Novacyt is 12.42 % in 2025.

Inventory to Revenue Ratio of Novacyt changed from 11.56 % to 12.42 %, representing a 7.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory to Revenue Ratio Novacyt since 2006 – with annual values, charts, and detailed analysis.

The Inventory/Revenue ratio shows what percentage of revenue is held as inventory. Rising ratios may indicate slowing demand or inventory management issues.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory to Revenue Ratio's Novacyt with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Novacyt

All Key Metrics — Novacyt